Compass Pathways Announces Publication of Post-Hoc Analysis Demonstrating Distinction of COMP360 Trial Monitoring & Support from Psychotherapy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. SPY
2. USO
3. IONQ
4. IONS
5. ACN
6. AZN
7. ROIV
8. AAPL
9. HOOD
10. QCOM

Go back to Compass Pathways Announces Publication of Post-Hoc Analysis Demonstrating Distinction of COMP360 Trial Monitoring & Support from Psychotherapy
(NASDAQ: CMPS) Delayed: 14.04 +0.77 (5.80%)
Previous Close $13.27    52 Week High $ 
Open $13.28    52 Week Low $ 
Day High $14.45    P/E N/A 
Day Low $13.18    EPS $ 
Volume 3,327,575